WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GPCR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$89.6M
Current Profit Margin
0%

GPCR Return on Equity

Current Company
-32.7%
Current Industry
-63.5%
Current Market
188%
GPCR's Return on Equity (-32.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GPCR announces earnings.

GPCR Return on Assets

Current Company
-30.5%
Current Industry
2.9%
GPCR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GPCR Return on Capital Employed

Current Company
-19.55%
Current Industry
19.5%
GPCR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GPCR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GPCR$0.00-$88.46M-$89.62MN/AN/A
FUSN$2.07M-$85.08M-$94.90M+19.84%N/A
SNDX$0.00-$208.40M-$209.36M-100.00%N/A
DNA$251.46M-$792.98M-$892.87M+46.77%N/A
AGIO$26.82M-$334.75M-$352.09M-22.25%N/A
View Top Biotech Stocks

GPCR earnings dates

Next earnings date
May 9, 2024

Structure Therapeutics Earnings & Revenue FAQ

What were GPCR's earnings last quarter?

On Invalid Date, Structure Therapeutics (NASDAQ: GPCR) reported Q4 2023 earnings per share (EPS) of -$0.48, up 86.32% year over year. Total Structure Therapeutics earnings for the quarter were -$24.50 million. In the same quarter last year, Structure Therapeutics's earnings per share (EPS) was -$3.51.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.

What was GPCR's earnings growth in the past year?

As of Q2 2024, Structure Therapeutics's earnings has grown year over year. Structure Therapeutics's earnings in the past year totalled -$89.62 million.

What is GPCR's earnings date?

Structure Therapeutics's earnings date is Invalid Date. Add GPCR to your watchlist to be reminded of GPCR's next earnings announcement.

What was GPCR's revenue last quarter?

On Invalid Date, Structure Therapeutics (NASDAQ: GPCR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Structure Therapeutics's revenue was $0.00.

What was GPCR's revenue growth in the past year?

As of Q2 2024, Structure Therapeutics's revenue has grown null year over year. Structure Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.